Resultats de la cerca - Tangen, Catherine M

Ongoing Use of Data and Specimens from NCI Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program per Minasian, Lori, Tangen, Catherine M., Wickerham, D. Lawrence

Obtenir text complet Obtenir text complet Obtenir text complet

Prostate-Specific Antigen: A Misused and Maligned Prostate Cancer Biomarker per Thompson, Ian M., Tangen, Catherine M., Kristal, Alan R.

Obtenir text complet Obtenir text complet Obtenir text complet

Prostate-Specific Antigen, Risk Factors, and Prostate Cancer: Confounders Nestled in an Enigma per Thompson, Ian M., Ankerst, Donna P., Tangen, Catherine M.

Obtenir text complet Obtenir text complet Obtenir text complet

Re: Long-term survival of participants in the Prostate Cancer Prevention Trial per Thompson, Ian M, Tangen, Catherine M, Goodman, Phyllis J

Obtenir text complet Obtenir text complet Obtenir text complet

Robustifying Trial-Derived Optimal Treatment Rules for A Target Population per Zhao, Ying-Qi, Zeng, Donglin, Tangen, Catherine M, LeBlanc, Michael L

Obtenir text complet Obtenir text complet Obtenir text complet

Failure to Achieve a Complete Response to Induction BCG Therapy is Associated with Increased Risk of Disease Worsening and Death in Patients with High Risk Non–Muscle Invasive Blad... per Lerner, Seth P., Tangen, Catherine M., Sucharew, Heidi, Wood, David, Crawford, E. David

Obtenir text complet Obtenir text complet Obtenir text complet

An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection per Vickers, Andrew J., Till, Cathee, Tangen, Catherine M., Lilja, Hans, Thompson, Ian M.

Obtenir text complet Obtenir text complet Obtenir text complet

PREDICTORS OF SURVIVAL IN ADVANCED RENAL CELL CARCINOMA: LONG-TERM RESULTS FROM SOUTHWEST ONCOLOGY GROUP TRIAL S8949 per Lara, Primo N., Tangen, Catherine M., Conlon, Sarah, Flanigan, Robert C., Crawford, E. David

Obtenir text complet Obtenir text complet Obtenir text complet

Does the level of prostate cancer risk affect cancer prevention with finasteride? per Thompson, Ian M., Tangen, Catherine M., Parnes, Howard L., Lippman, Scott M., Coltman, Charles A.

Obtenir text complet Obtenir text complet Obtenir text complet

Predicting Risk of Prostate Cancer in Men Receiving Finasteride: Effect of Prostate Volume, Number of Biopsy Cores, and American Urological Association Symptom Score per Ankerst, Donna P., Till, Cathee, Boeck, Andreas, Goodman, Phyllis J., Tangen, Catherine M., Thompson, Ian M.

Obtenir text complet Obtenir text complet Obtenir text complet

Alcohol Consumption, Finasteride and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial per Gong, Zhihong, Kristal, Alan R., Schenk, Jeannette M., Tangen, Catherine M., Goodman, Phyllis J., Thompson, Ian M.

Obtenir text complet Obtenir text complet Obtenir text complet

Biases in Recommendations for and Acceptance of Prostate Biopsy Significantly Affect Assessment of Prostate Cancer Risk Factors: Results From Two Large Randomized Clinical Trials per Tangen, Catherine M., Goodman, Phyllis J., Till, Cathee, Schenk, Jeannette M., Lucia, M. Scott, Thompson, Ian M.

Obtenir text complet Obtenir text complet Obtenir text complet

Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride per Dai, James Y., LeBlanc, Michael, Goodman, Phyllis J., Lucia, M. Scott, Thompson, Ian M., Tangen, Catherine M.

Obtenir text complet Obtenir text complet Obtenir text complet

Variations in Prostate Biopsy Recommendation and Acceptance Confound Evaluation of Risk Factors for Prostate Cancer: Examining Race and BMI per Tangen, Catherine M., Schenk, Jeannette, Till, Cathee, Goodman, Phyllis J., Barrington, Wendy, Lucia, M. Scott, Thompson, Ian M.

Obtenir text complet Obtenir text complet Obtenir text complet

Indications For and Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial per Schenk, Jeannette M., Calip, Gregory S., Tangen, Catherine M., Goodman, Phyllis, Parsons, J. Kellogg, Thompson, Ian M., Kristal, Alan R.

Obtenir text complet Obtenir text complet Obtenir text complet

Retention of Black and White Participants in the Selenium and Vitamin E Cancer Prevention Trial (SWOG-Coordinated Intergroup Study S0000) per Arnold, Kathryn B., Hermos, John, Anderson, Karen B., Minasian, Lori, Tangen, Catherine M., Probstfield, Jeffrey F., Cook, Elise D.

Obtenir text complet Obtenir text complet Obtenir text complet

Serum Adiponectin, C-peptide and Leptin and Risk of Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial per Schenk, Jeannette M., Kristal, Alan R., Neuhouser, Marian L., Tangen, Catherine M., White, Emily, Lin, Daniel W., Thompson, Ian M.

Obtenir text complet Obtenir text complet Obtenir text complet

A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT) per Martinez, Erin E., Darke, Amy K., Tangen, Catherine M., Goodman, Phyllis J., Fowke, Jay H., Klein, Eric A., Abdulkadir, Sarki A.

Obtenir text complet Obtenir text complet Obtenir text complet

Biomarkers of Systemic Inflammation and Risk of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial per Schenk, Jeannette M., Kristal, Alan R., Neuhouser, Marian L., Tangen, Catherine M., White, Emily, Lin, Daniel W., Kratz, Mario, Thompson, Ian M.

Obtenir text complet Obtenir text complet Obtenir text complet

Evaluation of Vitamin E and Selenium Supplementation for the Prevention of Bladder Cancer in SWOG Coordinated SELECT per Lotan, Yair, Goodman, Phyllis J., Youssef, Ramy F., Svatek, Robert S., Shariat, Shahrokh F., Tangen, Catherine M., Thompson, Ian M., Klein, Eric A.

Obtenir text complet Obtenir text complet Obtenir text complet